Day One Biopharmaceuticals, Inc. (DAWN): Price and Financial Metrics

Day One Biopharmaceuticals, Inc. (DAWN): $14.65

0.07 (-0.48%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add DAWN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#168 of 328

in industry

DAWN Price/Volume Stats

Current price $14.65 52-week high $18.07
Prev. close $14.72 52-week low $10.90
Day low $14.37 Volume 1,194,300
Day high $15.17 Avg. volume 937,221
50-day MA $14.20 Dividend yield N/A
200-day MA $14.61 Market Cap 1.48B

DAWN Stock Price Chart Interactive Chart >


Day One Biopharmaceuticals, Inc. (DAWN) Company Bio


Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.


DAWN Latest News Stream


Event/Time News Detail
Loading, please wait...

DAWN Latest Social Stream


Loading social stream, please wait...

View Full DAWN Social Stream

DAWN Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!